Reports Q3 revenue $224.5M, consensus $220.39M. “The Inspire team had a very productive third quarter focusing on the transition to the Inspire V system while delivering very strong results globally,” said Tim Herbert, Chairman and Chief Executive Officer of Inspire Medical (INSP) Systems. “Further, at recent industry meetings, we presented clinical evidence demonstrating that the Inspire V system offers enhanced performance, building on the strong foundation established by our legacy systems.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INSP:
- INSP Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Inspire Medical’s EURO-STIM Registry: A Long-Term Look at Sleep Apnea Treatment
- Inspire Medical’s New Study: Expanding Horizons for OSA Treatment
- Inspire Medical’s Pediatric Study: A Closer Look at the OSA Treatment Registry
- Inspire Medical’s New Study on Sleep Apnea in Down Syndrome Patients: A Market Game Changer?